Women in the third trimester of pregnancy who take supplements of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) reduce their children’s risk of persistent wheeze or asthma as well as of lower respiratory tract infections, a study in Denmark demonstrated.
A leading asthma inhaler will now be available to additional younger asthma patients, after FDA approved Spiriva Respimat (Boehringer Ingelheim) for the long-term, once-daily maintenance treatment of asthma in people age 6 and older.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a recent study published in the American Journal of Respiratory and Critical Care Medicine that looked at whether asthma in childhood contributed to the development of childhood obesity.
A study looks at the effectiveness of a dendritic cell vaccine in early-stage HER2-positive breast cancer. Plus: A look at whether fish oil consumed during pregnancy reduces the risk of asthma in offspring.
Results of a randomized trial in children with asthma comparing concomitant use of the inhaled glucocorticoid fluticasone propionate plus the long-acting beta-agonist (LABA) salmeterol with use of fluticasone alone indicate that the answer to this question is “no.”